Exocrine Pancreatic Insufficiency (EPI)

A 52 year old male with a history of long-standing alcohol use and chronic pancreatitis presents with progressive weight loss, bulky foul-smelling stools, and chronic diarrhea over several months. He reports that the stools are difficult to flush and appear oily. He also notes fatigue and easy bruising. Physical examination reveals mild muscle wasting. Laboratory evaluation shows increased fecal fat and markedly reduced fecal elastase. Diagnosis?

Diagnosis is Exocrine Pancreatic Insufficiency (EPI).

1. Definition

Exocrine Pancreatic Insufficiency (EPI) is a disorder characterized by reduced delivery of pancreatic enzymes into the intestinal lumen resulting in impaired digestion and nutrient absorption, particularly of fats.

The deficiency primarily involves:

1. Lipase
2. Protease
3. Amylase

2. Etiology

1. Chronic pancreatitis (most common in adults)
2. Cystic fibrosis (common in children)
3. Pancreatic duct obstruction:
• Tumors
• Strictures
4. Pancreatic cancer (especially pancreatic duct obstruction)
5. Other causes:
• Pancreatic resection
• Severe pancreatic atrophy
• Advanced pancreatic disease

3. Pathophysiology

1. Reduced delivery of pancreatic enzymes into the intestinal lumen
2. Reduced availability of:
• Lipase
• Protease
• Amylase
3. Impaired luminal digestion results in:
• Fat malabsorption
• Protein malabsorption
4. Fat malabsorption predominates because:
• Lipase deficiency develops earliest
• Fat digestion has limited compensation
5. Clinically significant carbohydrate malabsorption is less prominent because brush-border and salivary compensation exists
6. Consequences:
• Steatorrhea
• Weight loss
• Fat-soluble vitamin deficiency

4. Clinical Features

4.1 Core Features

1. Steatorrhea
• Bulky
• Greasy
• Foul-smelling
• Difficult-to-flush stools
2. Weight loss
3. Chronic diarrhea
4. Bloating

Additional high-yield point:

• Symptoms often appear only after >90% exocrine pancreatic function loss

4.2 Associated Features

1. Fat-soluble vitamin deficiency:
• Vitamin A deficiency
• Vitamin D deficiency
• Vitamin E deficiency
• Vitamin K deficiency
2. Nutritional consequences:
• Muscle wasting
• Osteopenia or osteoporosis
• Easy bruising
3. Advanced disease:
• Protein-calorie malnutrition

5. Diagnosis

5.1 Laboratory Evaluation

1. Fecal elastase
• >200 µg/g → normal
• 100–200 µg/g → indeterminate / mild to moderate EPI
• <100 µg/g → severe EPI
2. Important limitation:
• Fecal elastase may be falsely low in watery diarrhea
3. Fecal fat
• Increased
4. Nutritional evaluation:
• Fat-soluble vitamin levels

5.2 Imaging

1. Pancreatic imaging:
• CT
• MRI
• Endoscopic ultrasound

Purpose:

• Identify underlying pancreatic disease

6. Management

6.1 Pancreatic Enzyme Replacement Therapy (PERT)

1. Pancreatic enzyme replacement therapy

Administration:

• Take during meals
• Dose is usually based on lipase units
• Consider acid suppression if response is inadequate

6.2 Nutritional Support

1. Monitor and replace:
• Vitamin A
• Vitamin D
• Vitamin E
• Vitamin K
2. Consider:
• Nutritional markers
• Bone health assessment
3. Patients should generally maintain normal fat intake while receiving adequate enzyme replacement
4. Treat the underlying cause

7. Key Clinical Insight

Steatorrhea + weight loss + low fecal elastase + history of pancreatic disease strongly suggests Exocrine Pancreatic Insufficiency

8. Exam Level Pearls

1. Primary defect is failure of luminal digestion
2. Lipase deficiency causes the earliest and most prominent symptoms
3. Fecal elastase <100 µg/g strongly supports severe EPI
4. Chronic pancreatitis is the most common adult cause
5. Symptoms often appear after >90% exocrine function loss
6. Treatment is pancreatic enzyme replacement plus nutritional and vitamin support